Litcius/Paper detail

De Novo ANCA-Associated Vasculitis With Glomerulonephritis in COVID-19

Nupur N. Uppal, Nina Kello, Hitesh H. Shah, Yuriy Khanin, Ivan Ramirez De Oleo, Edward Epstein, Purva Sharma, Christopher P. Larsen, Vanesa Bijol, Kenar D. Jhaveri

2020Kidney International Reports144 citationsDOIOpen Access PDF

Abstract

Coronavirus disease 2019 (COVID-19) is a pandemic caused by a novel coronavirus that has been identified to belong to the β-coronavirus family.1 As the COVID-19 pandemic continues to evolve, more aspects of this illness are being defined and described. In the United States, the incidence of acute kidney injury (AKI) in patients hospitalized with COVID-19 has been reported to be around 37%.2 Different autopsy and kidney biopsy series have revealed acute tubular injury (ATI) to be the most common renal pathology lesion in these patients.

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)PandemicAcute kidney injurySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakCoronavirusVasculitisIncidence (geometry)AutopsyPathologyGlomerulonephritisRenal biopsyLesionKidneyBiopsyDiseaseInternal medicineOutbreakInfectious disease (medical specialty)OpticsPhysicsCOVID-19 Clinical Research StudiesVasculitis and related conditionsRetinal and Optic Conditions
De Novo ANCA-Associated Vasculitis With Glomerulonephritis in COVID-19 | Litcius